How does COVID-19 vaccination affect long-COVID symptoms?
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0296680 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ali A Asadi-Pooya und 12 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome, COVID-19. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The current study aimed to identify the association between COVID-19 vaccination and prolonged post-COVID symptoms (long-COVID) in adults who reported suffering from this condition.
Methods
This was a retrospective follow-up study of adults with long-COVID syndrome. The data were collected during a phone call to the participants in January-February 2022. We inquired about their current health status and also their vaccination status if they agreed to participate.
Results
In total, 1236 people were studied; 543 individuals reported suffering from long long- COVID (43.9%). Chi square test showed that 15 out of 51 people (29.4%) with no vaccination and 528 out of 1185 participants (44.6%) who received at least one dose of any vaccine had long long- COVID symptoms (p = 0.032).
Conclusions
In people who have already contracted COVID-19 and now suffer from long-COVID, receiving a COVID vaccination has a significant association with prolonged symptoms of long-COVID for more than one year after the initial infection. However, vaccines reduce the risk of severe COVID-19 (including reinfections) and its catastrophic consequences (e.g., death). Therefore, it is strongly recommended that all people, even those with a history of COVID-19, receive vaccines to protect themselves against this fatal viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, PA, United States of America.
- Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Burn & Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- HIV and AIDS Research Center, Department of Infectious Disease and Family Medicine, Shiraz University of Medical Science, Shiraz, Iran.
ORCID-Profile: Ali A Asadi-Pooya, Afrooz Karimi, Amir Emami
Zitieren
APA
Asadi-Pooya, A. A., Nemati, M., Shahisavandi, M., Nemati, H., Karimi, A., Jafari, A., Nasiri, S., Mohammadi, S. S., Rahimian, Z., Bayat, H., Akbari, A., Emami, A., & Eilami, O. (2024). How does COVID-19 vaccination affect long-COVID symptoms?. PLOS ONE. https://doi.org/10.1371/journal.pone.0296680
Vancouver
Asadi-Pooya AA, Nemati M, Shahisavandi M, Nemati H, Karimi A, Jafari A, et al. How does COVID-19 vaccination affect long-COVID symptoms?. PLOS ONE. 2024. doi:10.1371/journal.pone.0296680
BibTeX
@article{AsadiPooya2024,
author = {Asadi-Pooya, Ali A and Nemati, Meshkat and Shahisavandi, Mina and Nemati, Hamid and Karimi, Afrooz and Jafari, Anahita and Nasiri, Sara and Mohammadi, Seyyed Saeed and Rahimian, Zahra and Bayat, Hossein and Akbari, Ali and Emami, Amir and Eilami, Owrang},
title = {How does COVID-19 vaccination affect long-COVID symptoms?},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0296680}
}
EUVIMED